Kleiner Perkins startup could spell new era for Amgen
IN THIS ARTICLE
- Banking & Finance Topic
- Stephen Nellis Author
By Stephen Nellis Friday, November 2nd, 2012
In a sign that its pipeline strategy might be shifting, Thousand Oaks-based Amgen has paired up with one of the most prominent venture capital firms in Silicon Valley to start a new company to develop six of its drug ideas. Atara Biotherapeutics will be financed by Kleiner Perkins Caufield & Byers, which will retain a…